ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS

Clinical trials for ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS explained in plain language.

Never miss a new study

Get alerted when new ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS trials appear

Sign up with your email to follow new studies for ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New liquid drug tested for rare lung bleeding condition in ventilated patients

Disease control Recruiting now

This early-stage study looks at how the body processes a liquid version of the drug avacopan in up to 6 patients with a rare autoimmune disease (ANCA vasculitis) who have severe lung bleeding and need a breathing machine. Researchers will measure drug levels in the blood over 72 …

Matched conditions: ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS

Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control

Last updated May 06, 2026 16:13 UTC

ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS

Get alerted when new ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS trials appear

New liquid drug tested for rare lung bleeding condition in ventilated patients